Gazala Khan

Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Edward Kim, Vaibhav Sahai, Ethan V. Abel et al. · Clinical Cancer Research · 2014 · 306 citations · Full text

Medicine, Oncology, Pharmacology +17

A Phase I/II Trial of Intensity Modulated Radiation (IMRT) Dose Escalation With Concurrent Fixed-dose Rate Gemcitabine (FDR-G) in Patients With Unresectable Pancreatic Cancer

Edgar Ben‐Josef, Mathew J. Schipper, Isaac R. Francis et al. · International Journal of Radiation Oncology*Biology*Physics · 2012 · 187 citations

Medicine, Oncology, Radiation Oncology +17

A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor

Johanna C. Bendell, Milind Javle, Tanios Bekaii‐Saab et al. · British Journal of Cancer · 2017 · 133 citations · Full text

Medicine, Oncology, Pharmacology +15

Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer

Moumita Chatterjee, Edgar Ben‐Josef, Dafydd G. Thomas et al. · Scientific Reports · 2015 · 103 citations · Full text

Medicine, Cancer Biology, Radiation Oncology +17

Pomegranate Fruit Extract Impairs Invasion and Motility in Human Breast Cancer

Gazala Khan, Michael A. Gorin, Devin T. Rosenthal et al. · Integrative Cancer Therapies · 2009 · 83 citations · Full text

Medicine, Cancer Biology, Oncology +14